help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 5, 2006
Endocrinology, doi:10.1210/en.2006-1132
A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/1/160    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chinen, I.
Right arrow Articles by Takasu, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinen, I.
Right arrow Articles by Takasu, N.

Submitted on August 18, 2006
Accepted on September 26, 2006

Vascular lipotoxicity: endothelial dysfunction via fatty acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats

Ichiro Chinen, Michio Shimabukuro*, Ken Yamakawa, Namio Higa, Toshihiro Matsuzaki, Katsuhiko Noguchi, Shinichiro Ueda, Matao Sakanashi, and Nobuyuki Takasu

Second Department of Internal Medicine (IC, MS, NH, NT), Department of Clinical Pharmacology and Therapeutics (KY, SU), and Department of Pharmacology (TM, KN, MS), Faculty of Medicine, University of the Ryukyus, Okinawa, Japan

* To whom correspondence should be addressed. E-mail: mshimabukuro-ur{at}umin.ac.jp or me447945@members.interq.or.jp.

Vascular endothelial dysfunction has been demonstrated in obesity, but the molecular basis for this link has not been clarified. We examined the role of free fatty acids (FFA) on vascular reactivity in obese fa/fa Zucker Diabetic Fatty (ZDF) rat. Addition of acetylcholine produced a dose-dependent relaxation in aortic rings of ZDF and lean +/+ rats, but ED50 value was higher in ZDF (-6.80 ± 0.05 vs. -7.111 ± 0.05 log10mol/liter, P = 0.033). Two week treatment with a 3-hydroxy-3-methylglutaryl CoA reductase inhibitor, pitavastatin (3 mg/kg/per day), or a NADPH oxidase inhibitor, apocynin (5 mmol/liter in drinking water), improved the response in ZDF (ED50 -7.16 ± 0.03 and -7.14 ± 0.05 log10mol/liter, P = 0.008 and P = 0.015 vs. vehicle, respectively). Vasodilator responses to sodium nitroprusside was identical between ZDF and +/+ rats. Vascular reactive oxygen species (ROS) levels and NADPH oxidase activity in aorta were increased in ZDF rats but were decreased by pitavastatin. In in vitro cell culture, intracellular ROS signal and NADPH oxidase subunit mRNA were increased by palmitate but this palmitate-induced ROS production was inhibited by NADPH oxidase inhibitor or pitavastatin. In conclusion, FFA-induced NADPH oxidase subunit overexpression and ROS production could be involved in endothelial dysfunction seen in obese ZDF rats, and this could be protected by pitavastatin or NADPH oxidase inhibitors.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
O. Dumont, F. Pinaud, A.-L. Guihot, C. Baufreton, L. Loufrani, and D. Henrion
Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine
Cardiovasc Res, February 1, 2008; 77(3): 600 - 608.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Shimabukuro, I. Chinen, N. Higa, N. Takasu, K. Yamakawa, and S. Ueda
Effects of dietary composition on postprandial endothelial function and adiponectin concentrations in healthy humans: a crossover controlled study
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 923 - 928.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
I. M. Wahba and R. H. Mak
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society